• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

From clinical trials to clinical practice: generalizing from participant to patient.

作者信息

Rubins H B

机构信息

Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minnesota.

出版信息

Control Clin Trials. 1994 Feb;15(1):7-10. doi: 10.1016/0197-2456(94)90022-1.

DOI:10.1016/0197-2456(94)90022-1
PMID:8149772
Abstract

This paper uses the report of the Lipid Research Clinics Coronary Primary Prevention Trial as an example of how clinicians apply the results of clinical trials to their practice. Clinical trials influence practice primarily to the extent that they eventually become incorporated into the generally accepted standard of medical care. To a lesser extent, physicians are influenced by their own interpretation of clinical trial results. Since physicians usually do not have the leisure or the technical expertise to evaluate primary data critically, their conclusions are heavily influenced by the authors' sometimes overoptimistic interpretation of the results. Therefore, practicing clinicians often overestimate the benefits of a therapy and generalize the results of a trial too broadly. Ideally, physicians should base treatment decisions on their knowledge of the pathophysiology of the disease, the mechanism of action of the proposed treatment, and the clinical characteristics of the individual patient while informing their decision with a critical understanding of the results of relevant trials.

摘要

相似文献

1
From clinical trials to clinical practice: generalizing from participant to patient.
Control Clin Trials. 1994 Feb;15(1):7-10. doi: 10.1016/0197-2456(94)90022-1.
2
The lipid hypothesis is proven.脂质假说已得到证实。
Med J Aust. 1984 Mar 17;140(6):316-7. doi: 10.5694/j.1326-5377.1984.tb104080.x.
3
Generalizing from clinical trials.从临床试验进行推广。
Control Clin Trials. 1994 Feb;15(1):11-4. doi: 10.1016/0197-2456(94)90023-x.
4
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.脂质研究诊所冠心病一级预防试验结果。I. 冠心病发病率的降低
JAMA. 1984 Jan 20;251(3):351-64. doi: 10.1001/jama.1984.03340270029025.
5
Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Am J Cardiol. 1984 Aug 27;54(5):30C-34C. doi: 10.1016/0002-9149(84)90854-3.
6
The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.脂质研究诊所冠心病一级预防试验。试验后6年随访结果。脂质研究诊所研究人员。
Arch Intern Med. 1992 Jul;152(7):1399-410.
7
The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Monogr Atheroscler. 1985;13:74-84.
8
The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program.
J Chronic Dis. 1979;32(9-10):609-31. doi: 10.1016/0021-9681(79)90092-4.
9
Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
JAMA. 1985 Apr 12;253(14):2091-3.
10
NHLBI workshop on the Lipid Research Clinics Coronary Primary Prevention Trial.
Arteriosclerosis. 1985 Jul-Aug;5(4):397-403.

引用本文的文献

1
Economic incentives and disincentives for efficient prescribing.高效处方的经济激励与抑制因素。
Pharmacoeconomics. 1994 Sep;6(3):222-32. doi: 10.2165/00019053-199406030-00006.
2
Treatment for survivors of acute myocardial infarction: what have we learned from large intervention trials?
Cardiovasc Drugs Ther. 1995 Aug;9 Suppl 3:495-502. doi: 10.1007/BF00877861.